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Background: After the re-emergence of Plasmodium vivax in 1993, a total of 31,254 cases of vivax malaria were
reported between 1993–2012 in the Republic of Korea (ROK). The purpose of this study was to review Korea
Centers for Disease Control and Prevention records to investigate the transmission of malaria from 2010–2012.
Methods: Reporting of microscopy-diagnosed cases of malaria is mandatory in the ROK. In this study, all available
records of malaria cases and malaria vectors collected from 2010 – 2012 in Cheorwon County, Gangwon Province
and Ganghwa County, Incheon Metropolitan City, were reviewed.
Results: Although the number of cases of malaria peaked a third time in 2010 (1,772 cases) since the re-emergence
of P. vivax, the incidence decreased two-fold to 838 in 2011 and three-fold to 555 in 2012. The number of cases
decreased 52.7% in 2011 compared with that in 2010 and 33.8% in 2012 compared with that in 2011. However, the
number of cases increased in Incheon Metropolitan City (15.3%) and Gyeongnam Province (23.1%) in 2012
compared with 2011. Of the 3,165 cases of vivax malaria in 2010–2012, 798 (25.2%) were in ROK military personnel,
519 (16.4%) in veterans, and 1,848 (58.4%) in civilians. In total, there were 2,666 male patients and 499 female
patients, and the ratio of female to male patients increased from 1:7.9 in 2011 to 1:4.1 in 2012.
Conclusions: A rapid decrease in the incidence of malaria was observed in most areas from 2010 to 2012, but the
incidence increased again in the western part of the demilitarized zone. Therefore, more intensive surveillance is
needed throughout high risk areas to identify factors responsible for increase/decrease in the incidence of malaria
in the ROK.Background
Plasmodium vivax is the causative agent of relapsing be-
nign tertian human malaria, the second most common
type of malaria in humans, that afflicts several hundred
million people annually in the world. Vivax malaria is a
major public health problem in many tropical and semi-
tropical regions and temperate countries, including the
Democratic People’s Republic of Korea (DPRK) and the
Republic of Korea (ROK) [1].
The first scientific documentation of malaria was pub-
lished in 1913, although it had been prevalent throughout
the Korean peninsula for several centuries [2]. As a result* Correspondence: rainlee67@naver.com
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reproduction in any medium, provided the orof a national malaria eradication programme conducted in
cooperation with the World Health Organization (WHO),
the incidence of vivax malaria in the ROK rapidly de-
creased until in 1979 when WHO declared the ROK to be
malaria free [3-5]. In the 1980’s two sporadic cases were
detected [6] and in 1993, a ROK soldier serving in
northern Gyeonggi Province [7], and two civilians were
diagnosed with vivax malaria [8]. Thereafter, a number
of malaria cases were reported near the demilitarized
zone (DMZ), which centers on Paju-si, Yeoncheon-gun,
Cheorwon-gun, Gimpo-si, Ganghwa-gun, Goyang-si, and
Dongducheon-si.
During the first few years of re-emergence of vivax
malaria in the ROK, most cases occurred in ROK military
personnel deployed near the DMZ. But some civilians
who live in Daeseongdong where located inside of DMZ
and Tongilchon surrounded by ROK military installations. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ROK military personnel. In addition, as the number of
malaria cases increased, the ratio of civilian cases were
increased [9].
Thus, it was of considerable concern that vivax malaria
might become re-established through out the ROK as
veteran soldiers returned to their hometowns throughout
all of Korea [10-12].
The aim of this study was to determine the annual num-
ber of patients with malaria among military personnel, vet-
erans, and civilians in the ROK; the mean daily incidence
for weekly intervals; the geographic distribution of cases
among military personnel and civilians; and the number of
Anopheles mosquitoes captured by black light trap in the
malaria risk from 2010–2012 to analyse the current status
of malaria in the ROK.
Methods
Ethics statement
All participants were informed about the study method-
ology and provided written informed consent according to
ethical standards. The study procedures, potential risks,
and benefits were explained to all participants. All adult
participants and parents/guardians in the household of
participants under 18 years of age provided informed con-
sent. Parents who were unwilling to have their children
participate in the study were identified and their children
subsequently excluded without prejudice from study sur-
veys. All patient data were anonymous. The Human Ethics
Committee of Inha University provided ethical approval,
and this study was conducted according to the principles
expressed in the Declaration of Helsinki.
Data collection from patients with malaria
Malaria is classified as one of the Group III communicable
diseases that should be controlled by the Korean govern-
ment. For the convenience of data analysis, patients with
malaria were categorized as civilians, veterans, and mili-
tary personnel. For civilians and veterans (who were diag-
nosed with vivax malaria within 24 months of discharge
from military service in malaria epidemic areas), cases of
malaria detected in private hospitals or clinics are reported
to the local Public Health Center (PHC). The data col-
lected by the PHCs is provided periodically to the Division
of Infectious Disease Surveillance, Korea Centers for
Disease Control and Prevention. For military personnel,
cases of malaria are reported to the Office of the Surgeon
General, Army Headquarters, and the Ministry of Health
and Welfare [13]. The report usually contains the patient’s
name, age, sex, address, date of onset of illness, date of
diagnosis of malaria, and estimated areas where possibly
infected. Most cases of malaria diagnosed in civilian
hospital or health clinics include veterans, but might
also include ROK soldiers who were diagnosed whileleave. However, these cases among ROK soldiers are
excluded from the civilian/veteran populations by the
Division of Infectious Disease Surveillance, since the pa-
tients are contacted directly as part of the verification
process [14,15].
Definition of malaria
Thick and thin blood films obtained from suspected
malaria patients were fixed with methanol and stained
with Giemsa diluted with buffered water at pH 7.2 in
accordance with standard procedure [16]. To estimate
the densities of blood-stage parasites, the numbers of
parasites were counted relative to 200 white blood cells
(WBCs) and then the parasite/WBC ratio was multiplied
by 8,000 (estimated number of WBCs per microlitre of
blood) [17].
Geographic distribution of patients with malaria
The annual geographic distribution of P. vivax malaria
in civilians, veterans, and ROK military personnel was
determined by the patients residence and travel history
during diagnosis. The seasonal incidence was analysed
by grouping cases at weekly or monthly intervals.
Calculation of the annual parasite incidence
The annual parasite incidence (API) was calculated as the
number of malaria-positive patients per 1,000 inhabitants
for each of the study sites: API = (number of micro-
scopically proven malaria cases/1,000 population/year).
Density of Anopheles mosquitoes
The number of Anopheles mosquitoes was monitored
using a black light traps in Gyodong-myeon (Figure 1A, I)
and Samsan-myeon (Figure 1A, II), Ganghwa County of
Incheon Metropolitan City and Cheorwon-eup (Figure 1B,
III) and Gimhwa-eup (Figure 1B, IV), Cheorwon County
of Gangwon Province in the ROK during the malaria
transmission season from 2010–2012. Mosquito collec-
tions were conducted twice a week between 8 PM and
7 AM from April - October, at the same collection sites
for comparative analysis. Female mosquitoes were identi-
fied using morphological differences and counted regard-
less of the blood-fed status or malaria parasite infectivity.
The average of the number of collected mosquitoes over
two days was considered a representative value for the
week [14].
Results
Overview of malaria in the past two decades
A total of 31,254 cases of vivax malaria were reported
from 1993–2012 (Figure 2). In total, 9,501 cases (30.4%)
were reported in ROK military soldiers, 7,658 cases
(24.5%) in veterans who served in malaria risk areas, and
14,095 cases (45.1%) in civilians during the 20 years after
AB
Figure 1 Locations where collected mosquitoes by black light traps. A, Ganghwa County; B, Cheorwon County. Mosquito collection area:
















































































Figure 2 The annual number of vivax malaria cases from 1993–2012.
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Table 1 Annual number (percent of total) of Plasmodium
vivax cases among ROK military personnel, veterans, and
civilians
2010 2011 2012 Total
Veteran 295 (16.6%) 167 (19.9%) 57 (10.3%) 519 (16.4%)
Soldier 430 (24.3%) 264 (31.5%) 104 (18.7%) 798 (25.2%)
Civilian 1047 (59.1%) 407 (48.6%) 394 (71.0%) 1848 (58.4%)
Total 1772 (56.0%) 838 (26.5%) 555 (17.5%) 3165
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three peaks in the incidence of vivax malaria during last
two decades, with 4,141 cases, 2,203 cases, and 1,772
cases in 2000, 2007, and 2010, respectively.
Patients with malaria from 2010–2012
A total of 3,165 vivax malaria cases were reported from
2010–2012, including 798 (25.2%) in soldiers, 519
(16.4%) in veterans (less than 2 years after active duty
service), and 1,848 (58.4%) in civilians (Table 1). The
proportion of annual number of civilian cases increased
from 48.6% in 2011 to 71.0% in 2012, while the proportion








Figure 3 Reported vivax malaria cases in the Republic of Korea (ROK)in 2011 to 104 (18.7%) in 2012 and from 167 (19.9%) in
2011 to 57 (10.3%) in 2012, respectively. Overall, the
annual proportion of malaria cases for 16 administrative
districts decreased 52.7% in 2011 compared to 2010 and
by 33.8% compared to 2011. However, the number of
cases reported from the Incheon Metropolitan City and
Gyeongnam Province (Figure 3) increased 15.3% and
23.1%, respectively, in 2012 (Table 2). In addition, the
US military reported a total of nine malaria cases during
2010–2012. Six cases were reported while deployed to
Korea (4 cases in 2010, 1 case in 2011, and 1 case in
2012), while three cases were reported after returning
to the USA (due to the long-incubation period of vivax
malaria, one case in 2010, 0 case in 2011, and two cases
in 2012).
Comparison of the API according to administrative areas
Overall, API decreased from 0.036 in 2010 to 0.017 in
2011 and 0.011 in 2012 (Table 3). In 2010, Gangwon
Province had the highest API at 0.123, followed by Incheon
Metropolitan City (0.093), Gyeonggi Province (0.069),
and Seoul Metropolitan City (0.029). In 2011, Gangwon



























by Province and Metropolitan Area. DMZ, Demilitarized Zone.
Table 2 Annual number and percent difference of



















Seoul 290 94 -67.6 67 -28.7
Busan 43 24 -44.2 7 -70.8
Daegu 19 16 -15.8 4 -75.0
Incheon 256 124 -51.6 143 +15.3
Gwangju 9 6 -33.3 1 -83.3
Daejeon 15 9 -40.0 4 -55.6
Ulsan 8 7 -12.5 3 -57.1
Provinces
Gyeonggi 818 389 -52.4 263 -32.4
Gangwon 184 94 -48.9 13 -86.2
Chungbuk 23 11 -52.2 8 -27.3
Chungnam 14 12 -14.3 7 -41.7
Jeonbuk 22 12 -45.5 5 -58.3
Jeonnam 21 11 -47.6 4 -63.6
Gyeongbuk 19 12 -36.8 8 -33.3
Gyeongnam 24 13 -45.8 16 +23.1
Jeju 7 4 -42.9 2 -50.0
Total 1772 838 -52.7 555 -33.8
Table 3 The number of Plasmodium vivax malaria
patients and annual parasite incidence from 2010-21012















Seoul 10,026,000 290 (0.029) 94 (0.009) 67 (0.007)
Busan 3,464,000 43 (0.012) 24 (0.007) 7 (0.002)
Daegu 2,477,000 19 (0.008) 16 (0.006) 4 (0.002)
Incheon 2,750,000 256 (0.093) 124 (0.045) 143 (0.052)
Gwangju 1,506,000 9 (0.006) 6 (0.004) 1 (0.001)
Daejeon 1,527,000 15 (0.010) 9 (0.006) 4 (0.003)
Ulsan 1,105,000 8 (0.007) 7 (0.006) 3 (0.003)
Provinces
Gyeonggi 11,788,000 818 (0.069) 389 (0.033) 263 (0.022)
Gangwon 1,496,000 184 (0.123) 94 (0.063) 13 (0.009)
Chungbuk 1,539,000 23 (0.015) 11 (0.007) 8 (0.005)
Chungnam 2,104,000 14 (0.007) 12 (0.006) 7 (0.003)
Jeonbuk 1,802,000 22 (0.012) 12 (0.007) 5 (0.003)
Jeonnam 1,772,000 21 (0.012) 11 (0.006) 4 (0.002)
Gyeongbuk 2,638,000 19 (0.007) 12 (0.005) 8 (0.003)
Gyeongnam 3,232,000 24 (0.007) 13 (0.004) 16 (0.005)
Jeju 552,000 7 (0.013) 4 (0.007) 2 (0.004)
Total 49,778,000 1,772 (0.036) 838 (0.017) 555 (0.011)
Kim et al. Malaria Journal 2013, 12:309 Page 5 of 9
http://www.malariajournal.com/content/12/1/309Incheon Metropolitan City (0.045), Gyeonggi Province
(0.033), and Seoul Metropolitan City (0.009). In 2012,
Incheon Metropolitan City had the highest API at
0.052, followed by Gyeonggi Province (0.022), Gangwon
Province (0.009), and Seoul Metropolitan City (0.007).
Most cases of malaria were reported from June
through September in 2010–2012 with the highest peaks
observed from the 29th week of 2010 (July 10–17) with
113 patients, in the 28th week of 2011 (July 2–9) with
63 patients, and in the 31st week of 2012 (July 28 to
August 4) with 42 patients (Figure 4). Interestingly, the
last apparent peaks of annual incidence during these three
years were approximately three weeks after Chuseok
(Korean Thanksgiving Day, which was on September 22 in
2010, September 12 in 2011, and September 30 in 2012),
that is, the 42nd week of 2010 (October 10–16) with 32
patients, the 40th week of 2011 (October 2–8) with 32
patients, and the 43rd week of 2012 (October 21–27) with
13 patients (Figure 4).
Sex ratio and occupation of vivax malaria patient
There were 2,666 male and 499 female patients with
vivax malaria from 2010–2012. The ratio of female to
male patients increased from 1:7.9 in 2011 to 1:4.1 in 2012(Figure 5). The most common occupation was soldier
(18.74–31.50%), followed by students (9.73–13.25%), and
farmers and fishermen (4.23–6.85%) (Figure 6).Density of Anopheles mosquitoes
A total of 67,566 An. sinensis sensu lato were collected in
2010, 5,022 in 2011, and 38,207 in 2010 in Ganghwa County
from April - October (Figure 7A). In Cheorwon County,
1,308 An. sinensis s.l. were collected in 2010, 228 in 2011,
and 2,427 in 2010 (Figure 7B). An. sinensis s.l. was first
detected during the 17th week in Cheorwon County in all
three years; however, in Ganghwa County, An. sinensis s.l.
was first detected during the 17th week of 2010, 18th week
of 2011, and 15th week of 2012 (Figure 7).
The highest density of An. sinensis s.l. was recorded
during the 33rd week (236) of 2010, the 34th week (42)
of 2011, and the 33rd week (696) of 2012 in Cheorwon
County. In Ganghwa County, the highest density of An.
sinensis s.l. was reported during the 34th week (14,848)
of 2010, the 36th week (1,027) of 2011, and the 33rd week
(9,909) of 2012. The number of An. sinensis s.l. was lowest
at the end of the surveillance period (Figure 7).






























Figure 4 The weekly incidence of vivax malaria in ROK patients from 2010–2012.
Kim et al. Malaria Journal 2013, 12:309 Page 6 of 9
http://www.malariajournal.com/content/12/1/309A total of 110,795 An. sinensis s.l. were collected in
Ganghwa County but only 3,963 were collected in
Cheorwon County (Figure 7). The high vector density
in Ganghwa County may have resulted in the high and
increased incidence of vivax malaria in that area.
Discussion
In North Korea, the high-risk areas of vivax malaria are
Gaeseong City, the South and North Hwanghae Provinces,
and Gangwon Province, which border the DMZ. The
DMZ is a 4-km-wide, 250-km-long corridor that extends
across the middle part of the Korean peninsula. In general,
no civilians have been allowed to enter the DMZ for more
than 60 years, even though one exceptional village called
“Daesungdong” is located inside of DMZ; therefore, nat-
ural ecosystems and biodiversity are highly conserved in
the DMZ [18]. To control malaria, North Korea has




























Figure 5 The sex ratio of patients with vivax malaria
from 2010–2012.primaquine (15 mg for 14 days) before the malaria trans-
mission season for civilians living in these areas since 2002
[19]. As a result, it was believed that transmission of mal-
aria occurred mainly in these areas in North Korea [20].
Therefore, the adjacent to malaria risk areas in North
Korea, high risk areas were observed in the ROK, e.g.,
Incheon Metropolitan City and northern Gyeonggi and
Gangwon provinces. There is no objective opinion that
mass chemoprophylaxis might largely decrease the num-
ber of malaria cases among military personnel, which may
alternatively decrease numbers of cases among civilian
populations. Chemoprophylaxis started with approxi-
mately 16,000 military personnel in 1997 and expanded
to more than 200,000 military personnel who are cur-
rently serving in malaria high risk areas [13]. Unfortu-
nately, it was found that prophylactic failure occurred
even in those who had sufficient plasma concentrations
of hydroxychloroquine. It means that a chloroquine-
resistant P. vivax strain has been reported in the ROK
[21]. The appearance of this drug-resistant strain is
troublesome for the treatment of patients in the future.
Therefore, another standard regimen should be considered
to replace the current regimen of chloroquine-primaquine.
However, it is not easy to find the next defensive line of
anti-malaria drugs because it has been reported that
Korean P. vivax isolates are already resistant to pyrimeth-
amine, which is recommended for use in patients with mal-
aria who fail to respond to chloroquine chemotheraphy
[22]. It was shown that the existence of antifolate-resistant
P. vivax in the ROK. Further detailed geographic mapping
of current and changing patterns of vivax malaria drug re-
sistance on a national or regional scale would prove a valu-
able aid for developing and updating national anti-malarial
policy guidelines in the ROK. Control measures and
inter-governmental co-operation are also needed to





















































































Figure 6 Occupations of vivax malaria patients from 2010–2012.
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http://www.malariajournal.com/content/12/1/309It was reported that six Anopheles species in the
ROK: Anopheles sinensis sensu stricto, Anopheles lesteri,
Anopheles pullus, Anopheles sineroides, Anopheles kleini,
and Anopheles belenrae [23-26]. These six species com-
prise a species complex called An. sinensis s.l. Because they
occur in sympatry and it is hard to distinguish by morph-















































Figure 7 The weekly number of Anopheles sinensis s.l. in Ganghwa Co
Gangwon Province (B) from 2010–2012.species. But it is hard to apply the newly developed
methods for classifications in the surveillance system until
developing more precise methods for identification of
Anopheles complex in real time manners. Therefore, An.
sinensis s.l. was presented in this study. Analysis of the
mosquito density of An. sinensis s.l. in study areas










unty, Incheon Metropolitan City (A) and Cheorwon County,
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(Figure 7). Therefore, the potential unknown threatening
factors including mosquito density still may exist on the
west side of malaria foci compared with the east side; this
explains why the API of Gangwon Province, which is the
representative location of the east side, was reduced
dramatically from 0.123 in 2010 to 0.063 in 2011 and to
0.009 in 2012 and the API of Incheon Metropolitan City
changed from 0.093 in 2010 to 0.045 in 2011 but increased
to 0.052 in 2012 (Table 3).
PHCs are responsible for controlling the transmission of
malaria in each of the vivax malaria risk area. As a result
of the anti-malaria efforts of the PHC in Cheorwon
County, which is a high-risk area in Gangwon Province,
the number of cases of malaria decreased dramatically to
low level, 27 cases in 2010, 14 cases in 2011, and two cases
in 2012. In Cheorwon County, nine cases were first
reported in 1997, while there was a peak of 166 cases in
2000 [27]. It took an average of 5.4 average days (4.2–7.0)
to confirm a case of malaria after onset during 2010–2012
(unpublished data). Anti-mosquito activities, including
fogging and residual spray, took place from April 8 to
October 5 in 2010, May 4 to October 4 in 2011, and May
4 to October 9 in 2012. In total, 748 L of insecticide and
129 L of larvicide were used in 2010, 1,037 L of insecticide
and 188 L of larvicide were used in 2011, and 807 L of
insecticide and 21 L of larvicide were used in 2012 to
cover an area of 36,592 m2. To obtain this level of cover-
age, activities were repeated approximately 1,442 times in
2010, 1,510 times in 2011, and 1,430 times in 2012 (data
from the PHC in Cheorwon County, Gangwon Province).
The interesting finding is that the last peak of each
year was shown the similar patterns in three years, that
is, increasing the malaria cases in three weeks after
Chuseok (Figure 4, ↓). This duration is matched with
the incubation period of vivax malaria in the liver. It
was probably due to the massive interregional popula-
tion movement throughout the ROK during Chuseok
from high risk areas to malaria free areas, in addition
increasing the activities during the night without self
protection from malaria vectors. It is suggested that sol-
diers who leave for vacation to their hometowns should be
either checked or treated for malaria just like retiring ex-
soldiers from their active military service (primaquine/
15 mg/14 days) [15,28,29].
To evaluate transmission of malaria in a given geographic
region, many factors, including temperature, mosquito
density, vector capacity, climate, rainfall, and humidity,
should be considered [30]. Patient incidence alone cannot
provide a complete understanding of the prevalence of mal-
aria in the ROK because there are many factors involved,
including the changes in weekly population density of mos-
quitoes due to environmental factors, vectorial capacity,
long- and short-incubation patient ratios, symptomaticand asymptomatic patient ratios, and differences in
weekly rainfall and temperatures. This study analysed
only two factors: incidence and An. sinensis s.l. However,
all factors indicated that transmission of malaria would ap-
parently be reduced except in Incheon Metropolitan
City and Gyeongnam Province. There are opportunities
for the eradication of malaria in the ROK due to sev-
eral efforts of the Korea CDC, Government Public
Institute of Health and Environment, PHCs, and re-
lated institutes.
Conclusions
The number of patients with vivax malaria in the ROK
peaked in 2010 for a third time over two decades and
then decreased in the subsequent two years. This was
the third time the number of cases of malaria peaked
since a trend of decreasing cases was observed in 2001.
It is expected that the number of cases of malaria will
continue to decrease in the future, although there may
be some fluctuations. However, more intensive malaria
surveillance is needed in the western part of the country
where foci have re-emerged to reduce the potential for
future increases in the number of malaria cases in the
ROK.
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